Kiniksa Outlines Next Steps for the Development of Mavrilimumab,

Kiniksa expects data from the Phase 3 portion of the clinical trial in the first quarter of 2022. Kiniksa is engaged with the FDA and other government …, Kiniksa expects data from the Phase 3 portion of the clinical trial in the first quarter of 2022. Kiniksa is engaged with the FDA and other government …, Read More

Scroll to Top